Target intelligence / Profile preview

Innate immune DNA sensor (DNA sensor)

Target
DNA sensor
Molecular classification
Pattern recognition receptor, Enzyme, Receptor
01

Overview

Innate immune DNA sensors are a diverse group of pattern recognition receptors (PRRs) that detect the presence of double-stranded DNA (dsDNA) in inappropriate cellular compartments, such as the cytoplasm or endosomes, which typically signals infection or cellular damage (PMID: 30635666). Key members include cyclic GMP-AMP synthase (cGAS), which produces the second messenger cGAMP to activate the Stimulator of Interferon Genes (STING) pathway, and Toll-like receptor 9 (TLR9), which recognizes unmethylated CpG motifs in endosomes (PMID: 28410988). Other sensors like Absent in melanoma 2 (AIM2) trigger the formation of the inflammasome, leading to IL-1β release and pyroptosis (PMID: 21327021). These sensors play a critical role in defending against viral and bacterial pathogens but can also be triggered by self-DNA in autoimmune conditions like systemic lupus erythematosus (SLE) (PMID: 31043709). In oncology, activating these pathways (particularly cGAS-STING) is a major strategy to turn cold tumors hot by promoting dendritic cell maturation and T-cell infiltration (PMID: 31439479). Conversely, inhibitors are being developed to treat autoinflammatory diseases driven by chronic DNA sensing (PMID: 30510223).

Other names
Cytosolic DNA sensorDNA-sensing pattern recognition receptorNucleic acid sensorIntracellular DNA sensor
02

Mechanism of action

Agonists bind to and activate sensors (e.g., STING, TLR9) to induce Type I interferons and pro-inflammatory cytokines for cancer immunotherapy; antagonists or inhibitors block DNA sensing or downstream signaling to treat autoimmune and autoinflammatory diseases (PMID: 30635666, 30510223).

03

Biological functions

Immune responseSignal transductionApoptosisInflammatory responseCytokine production
04

Disease associations

CancerAutoimmune diseaseInfectionInflammationNeurodegenerative disease
05

Safety considerations

Cytokine release syndromeInduction of autoimmunitySystemic inflammatory responseInjection site reactionsTissue damage
06

Interacting drugs

Lefitolimod

7 more in the full profile.

07

Biomarkers

CXCL10 (IP-10)Type I Interferon signature2',3'-cGAMPPhospho-STINGPhospho-IRF3

Beyond the preview

Go deeper on Innate immune DNA sensor (DNA sensor).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innate immune DNA sensor (DNA sensor).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call